No Detail Found!

Effect of Methylphenidate and buspirone-methylphenidate co- administration on biochemical and hematological parameters in rats: Implications for safe and confrontational use

Author(s)
Nausheen Alam Faculty of Pharmacy, Federal Urdu University of Arts Science & Technology,Karachi,Pakistan
Raheela Ikram Faculty of Pharmacy, Salim Habib University,Karachi,Pakistan
Sadaf Naeem Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University,Karachi,Pakistan
Saira Saeed Khan Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Tuba Siddiqui Faculty of Pharmacy, Federal Urdu University of Arts Science & Technology,Karachi,Pakistan
Humera Khatoon Faculty of Pharmacy, Jinnah University for Women,Karachi,Pakistan
Saadia Suri Kashif Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Abstract
Methylphenidate (MPH) is a psychostimulant, beneficial in attention deficit hyperactivity disorder (ADHD). Previously it has been shown that MPH-induced locomotor sensitization could be attenuate by buspirone co administration however the effect of chronic MPH and co-administration of MPH-buspirone on biochemical and hematological parameters are unknown. This study is designed to investigate these parameters after long term administration of MPH, Buspirone and their combination in rats. 40 male Wister rats were divided in to 4 groups, and treated with saline, MPH (2mg/kg/day), Buspirone (10mg/kg/day) and MPH-Buspirone co-administration (2mg/kg/day +10mg/kg/day; respectively) up to six weeks. Administration of MPH significantly increase blood glucose level in saline treated control rats, however co-administration of MPH-buspirone exhibited less effect on blood glucose levels. Serum creatinine levels significantly decreased in all treated groups as compared to control but highly significant results were seen with combination treatment. Co-administration of MPH-buspirone and buspirone treated rats exhibited increased cholesterol and hemoglobin values. All treated groups showed increased values of hematocrit, MCV, MCH and MCHC compared to control group. RBCs and WBC's count were decreased in all treated groups. The platelet count rose significantly by Buspirone and MPH-buspirone administration, while MPH showed decreased platelet count. Thus, results suggested that prolong co-administration of MPH-buspirone is safe and effective for ADHD patients by preventing adverse effects not only on behavioral but also on biochemical and hematological parameter.
Publication Details
Page(s) 2131-2139
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: 6, Year: 2021

Request the full text from PASTIC

Keywords
Methylphenidate, biochemical analysis, attention deficit hyperactivity disorder, buspirone, hematological assessment
0

Citations

0

Downloads

74

Views